Joe Timothy Bamberg,Johannes Cornelius Hermann,Michael Soth,Remy Lemoine
申请号：
BRPI0922937
公开号：
BRPI0922937A2
申请日:
2009.11.26
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to the use of novel pyrrolopyrazinyl urea derivatives of Formula I, wherein the variables R1, R2, R3, R4, and R5 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
